Evidence map›Paper›PMID 42296122›Full record

ArticlePLoS pathogens2026

Central Nervous System T-cell immune architecture, and not HIV burden, tracks with cognition under long-term viral suppression.

Mattia Trunfio, Gemma Caballero, Vanessa Gomez-Moreno, Simon A Mallal, Celestine N Wanjalla, Angela Jones, Karen Beeri, Alan Wells, Sarah LaMere, Ben Gouaux and 8 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mattia TrunfioDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.ORCID https://orcid.org/0000-0001-8663-719X
Gemma CaballeroDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Vanessa Gomez-MorenoDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Simon A MallalDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Celestine N WanjallaDivision of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Angela JonesVanderbilt Technologies for Advanced Genomics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Karen BeeriVanderbilt Technologies for Advanced Genomics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Alan WellsDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Sarah LaMereDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Ben GouauxDepartment of Psychiatry, University of California San Diego, San Diego, California, United States of America.
Donald R FranklinDepartment of Psychiatry, University of California San Diego, San Diego, California, United States of America.
Michael CorleyDivision of Geriatrics and Palliative Care, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Ronald J EllisDepartment of Psychiatry, University of California San Diego, San Diego, California, United States of America.
David J MooreDepartment of Psychiatry, University of California San Diego, San Diego, California, United States of America.
Scott L LetendreDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Davey SmithDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Antoine ChaillonDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
Sara GianellaDivision of Infectious Diseases and Global Health, Department of Medicine, University of California San Diego, La Jolla, California, United States of America.

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE75N95023C00014 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, DAVID J · 2023 to 2025
$6.6M
Brain Myeloid Cells are Sources of HIV-associated Damage and Viral DispersalR01DA055491 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHAILLON, ANTOINE · 2021 to 2025
$3.6M
Epigenetic profiling of HIV-associated neuroinflammation and proviral expression in the brainR01NS137852 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sarah Adrianne LaMere · 2024 to 2026
$2.4M
NIDA NIH HHS R01 DA055491NIH HHS 75N95023C00014NIMH NIH HHS P30 MH062512NIMH NIH HHS U24 MH100928NINDS NIH HHS R01 NS137852
6 · The paper itself

Abstract

Despite effective antiretroviral therapy, HIV persists in the central nervous system (CNS) and may contribute to neuroinflammation and cognitive impairment. How viral persistence, immune responses, and regional CNS T-cell architecture relate to cognitive functioning remains unclear. We performed a cross-sectional, multi-compartmental immune-genomic study in 12 people with HIV on long-term viral suppression enrolled in the Last Gift rapid autopsy program. Quantitative HIV reservoir measures (total-episomal DNA, unspliced-multiply spliced RNA) and paired αβ T-cell receptor repertoire (TCRR) sequencing were performed in peripheral blood mononuclear cells and five CNS regions: hippocampus, frontal motor cortex, basal ganglia, occipital cortex, and spinal cord. Cognitive performance was assessed within one year of death. Tissue-resolved associations between cognition and HIV reservoir, TCRR architecture (richness, diversity, clonality), and pathogen-specific T-cell clonotypes (HIV, CMV, EBV, and riboflavin derivatives) were evaluated using participant-clustered multivariable models. False discovery rate was applied. HIV DNA and RNA were detectable across all tissues but were not associated with cognitive performance or TCRR metrics. Peripheral TCRR architecture was unrelated to cognition, whereas higher TCRR richness and diversity in the hippocampus and spinal cord were associated with worse verbal, motor, and attention/working memory scores. Higher TCRR richness in the spinal cord was also associated with better recall. T-cell receptor clonotype frequency distributions differed across CNS regions, consistent with regional immune compartmentalization. Epitope-inference analyses revealed pathogen-dependent associations: higher number of HIV-specific T-cell clonotypes in the basal ganglia was associated with better global and attention/working memory scores, whereas riboflavin derivative-specific clonotypes in frontal motor cortex were associated with better motor performance. CMV-specific clonotypes showed nominal associations with worse learning and memory. CNS-localized T-cell receptor architecture and antigenic imprinting related more closely to neurocognitive variability than quantitative measures of HIV persistence under viral suppression, highlighting regional specialization of T-cell responses as a potential correlate of brain health.

Indexed as

Central Nervous SystemCognitionHIV-1HIV InfectionsT-LymphocytesAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedViral Load

Identifiers

PMID42296122
PMCPMC13286276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.